183 related articles for article (PubMed ID: 38560379)
1. Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
Rosenberg AGW; Mochèl K; Hähner LM; Ruules L; Davidse K; Bos-Roubos AG; van Dijk SA; Zillikens MC; Taal W; van der Lely AJ; de Graaff LCG
Front Endocrinol (Lausanne); 2023; 14():1119159. PubMed ID: 38560379
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Fatigue and Endocrine and Non-endocrine Health Problems in Turner Syndrome: Cohort Study and Review.
Rosenberg AGW; Dingemans VDA; Bos-Roubos AG; Luijks S; Dessens AB; Dykgraaf R; Roos-Hesselink JW; Van Rossum EFC; Van Der Lely AJ; De Graaff LCG
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1649-e1659. PubMed ID: 37296515
[TBL] [Abstract][Full Text] [Related]
3. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
4. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
6. Perceived fatigue in children and young adults with neurofibromatosis type 1.
Vassallo G; Mughal Z; Robinson L; Weisberg D; Roberts SA; Hupton E; Eelloo J; Burkitt Wright EM; Garg S; Lewis L; Evans DG; Stivaros SM
J Paediatr Child Health; 2020 Jun; 56(6):878-883. PubMed ID: 31916647
[TBL] [Abstract][Full Text] [Related]
7. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.
Crow AJD; Janssen JM; Marshall C; Moffit A; Brennan L; Kohler CG; Roalf DR; Moberg PJ
Am J Med Genet A; 2022 Aug; 188(8):2277-2292. PubMed ID: 35546306
[TBL] [Abstract][Full Text] [Related]
9. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
10. Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.
Castricum J; Tulen JHM; Taal W; Rietman AB; Elgersma Y
J Atten Disord; 2022 Feb; 26(4):563-572. PubMed ID: 33978520
[TBL] [Abstract][Full Text] [Related]
11. An update on the central nervous system manifestations of neurofibromatosis type 1.
Nix JS; Blakeley J; Rodriguez FJ
Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.
Plasschaert E; Descheemaeker MJ; Van Eylen L; Noens I; Steyaert J; Legius E
Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):72-80. PubMed ID: 25388972
[TBL] [Abstract][Full Text] [Related]
13. Optic pathway glioma and endocrine disorders in patients with and without NF1.
Gil Margolis M; Yackobovitz-Gavan M; Toledano H; Tenenbaum A; Cohen R; Phillip M; Shalitin S
Pediatr Res; 2023 Jan; 93(1):233-241. PubMed ID: 35538247
[TBL] [Abstract][Full Text] [Related]
14. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract][Full Text] [Related]
15. The impact of ADHD on the cognitive and academic functioning of children with NF1.
Pride NA; Payne JM; North KN
Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
[TBL] [Abstract][Full Text] [Related]
16. Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.
Chisholm AK; Anderson VA; Pride NA; Malarbi S; North KN; Payne JM
Neuropsychol Rev; 2018 Sep; 28(3):317-340. PubMed ID: 30097761
[TBL] [Abstract][Full Text] [Related]
17. Reading Comprehension Impairment in Children With Neurofibromatosis Type 1 (NF1): The Need of Multimodal Assessment of Attention.
Biotteau M; Tournay E; Baudou E; Destarac S; Iannuzzi S; Faure-Marie N; Castelnau P; Schweitzer E; Rodriguez D; Kemlin I; Dorison N; Rivier F; Carneiro M; Preclaire E; Barbarot S; Lauwers-Cancès V; Chaix Y
J Child Neurol; 2021 Jul; 36(8):625-634. PubMed ID: 33507832
[TBL] [Abstract][Full Text] [Related]
18. Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).
Eijk S; Mous SE; Dieleman GC; Dierckx B; Rietman AB; de Nijs PFA; Ten Hoopen LW; van Minkelen R; Elgersma Y; Catsman-Berrevoets CE; Oostenbrink R; Legerstee JS
J Autism Dev Disord; 2018 Jul; 48(7):2278-2285. PubMed ID: 29423604
[TBL] [Abstract][Full Text] [Related]
19. Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.
Doser K; Hove H; Østergaard JR; Bidstrup PE; Dalton SO; Handrup MM; Ejerskov C; Krøyer A; Doherty MA; Møllegaard Jepsen JR; Mulvihill JJ; Winther JF; Kenborg L
BMJ Open; 2022 Sep; 12(9):e065340. PubMed ID: 36127120
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
J Genet Couns; 2015 Dec; 24(6):931-44. PubMed ID: 25894096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
